INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹1.36 Cr | ₹4.24 Cr | ₹36 Cr | ₹40 Cr | ₹23 Cr |
What is the latest Contingent Liabilities ratio of INDSWIFT LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹1.36 Cr |
Mar2023 | ₹4.24 Cr |
Mar2022 | ₹36 Cr |
Mar2021 | ₹40 Cr |
Mar2020 | ₹23 Cr |
How is Contingent Liabilities of INDSWIFT LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1.36 Cr | -68.05 | |
Mar2023 | ₹4.24 Cr | -88.11 | |
Mar2022 | ₹36 Cr | -11.00 | |
Mar2021 | ₹40 Cr | 75.55 | |
Mar2020 | ₹23 Cr | - |
Compare Contingent Liabilities of peers of INDSWIFT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDSWIFT LABORATORIES | ₹569.2 Cr | 12.6% | -8% | -5.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,569.0 Cr | 2.8% | -7.5% | 2.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹146,318.0 Cr | -0.2% | -9.9% | 60.4% | Stock Analytics | |
CIPLA | ₹118,110.0 Cr | 4.4% | -0.6% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,926.0 Cr | 4.8% | -2.9% | 15.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,471.5 Cr | NA | -9.4% | -10.2% | Stock Analytics |
INDSWIFT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDSWIFT LABORATORIES | 12.6% |
-8% |
-5.5% |
SENSEX | 1.4% |
-5.3% |
0.3% |
You may also like the below Video Courses